Takeda Pharmaceutical Co Ltd  

(Public, TYO:4502)   Watch this stock  
Find more results for 4502
4,513.00
-53.00 (-1.16%)
Jul 26 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 4,496.00 - 4,565.00
52 week 4,098.00 - 6,609.00
Open 4,565.00
Vol. 2.46M
Mkt cap 3.57T
P/E 44.63
Div/yield 90.00/3.99
EPS 101.11
Shares 783.60M
Beta     -
Inst. own     -
Jul 29, 2016
Q1 2017 Takeda Pharmaceutical Co Ltd Earnings Press Conference (Japanese) - 6:30PM GMT+9 - Add to calendar
Jul 29, 2016
Q1 2017 Takeda Pharmaceutical Co Ltd Earnings Presentation (Japanese) - 5:15PM GMT+9 - Add to calendar
Jul 29, 2016
Q1 2017 Takeda Pharmaceutical Co Ltd Earnings Release - 3:00PM GMT+9 - Add to calendar
Jul 5, 2016
Tigenix NV and Takeda Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas Corporate Call
Jun 29, 2016
Takeda Pharmaceutical Co Ltd Annual Shareholders Meeting
Jun 24, 2016
Takeda Pharmaceutical Co Ltd Annual Shareholders Meeting (Estimated)
Jun 9, 2016
Takeda Pharmaceutical Co Ltd IR Day (Japanese)
May 10, 2016
Full Year 2016 Takeda Pharmaceutical Co Ltd Earnings Presentation
May 10, 2016
Full Year 2016 Takeda Pharmaceutical Co Ltd Earnings Presentation (Japanese)
May 10, 2016
Full Year 2016 Takeda Pharmaceutical Co Ltd Earnings Press Conference (Japanese)
  

Key stats and ratios

Q1 (Mar '16) 2016
Net profit margin -7.94% 4.62%
Operating margin -8.85% 6.95%
EBITD margin - 19.58%
Return on average assets -3.29% 2.06%
Return on average equity -6.64% 3.92%
Employees 31,168 -
CDP Score - 97 B

Address

4-1-1, Dosho-machi, Chuo-ku
OSAKA-SHI, OSK 540-8645
Japan
+81-6-62042111 (Phone)
+81-6-62042880 (Fax)

Website links

External links

Description

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. As of March 31, 2014, the Company had 146 subsidiaries and 17 associated companies.

Officers and directors

Yasuchika Hasegawa Chairman of the Board
Age: 69
Christophe Weber President, Chief Executive Officer, Representative Director
Age: 48
Andrew S. Plump Chief Medical & Scientific Officer, Director
Age: 50
Shinji Honda Senior Managing Director, Corporate Strategy Office, President of Subsidiary
Age: 57
Masato Iwasaki President of Japan Pharma Business Unit, Director
Age: 56
Yorihiko Kojima Independent Director
Age: 74
Masahiro Sakane Independent Director
Age: 75
Fumio Sudo Independent Director
Age: 75